Clinical parameters of growth hormone deficient (GHD, group 1) children at the end (T0) of rhGH therapy (T0), after 12 months rhGH withdrawal (T12) and of control subjects (CS, group 2). This evidence concerns the gene GH1 and hyperinsulinemic hypoglycemia, familial, 4.